STRS Ohio
SPTX icon

STRS Ohio’s Seaport Therapeutics SPTX Stock Holding History

STRS Ohio’s Portfolio SPTX Stock Details SPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$76.6K Buy
+3,800
New +$84.4K ﹤0.01% 1965

Other funds holding SPTX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

STRS Ohio's SPTX Position: Q3 2026 in Review

STRS Ohio opened a new position in Seaport Therapeutics (SPTX) in Q3 2026: 3,800 shares worth $76.6K. The stake represents ﹤0.01% of the portfolio and ranks #1965 among its holdings.

13 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.

  • STRS Ohio held 3,800 shares of Seaport Therapeutics worth $76.6K as of Q3 2026.
  • Seaport Therapeutics was a new STRS Ohio position in Q3 2026.
  • Seaport Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1965 holding.
  • 13 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.